Clover Health Investments (CLOV) shares were up 4.9% in recent Friday trading after the company announced that its preferred provider organizations Medicare Advantage plans were rated 4 stars for 2025 by the Centers for Medicare and Medicaid Services.
The company said this will affect payment year 2026, adding that over 95% of its Medicare Advantage membership is served through its PPO plans.
CMS also increased Clover's health maintenance organization Medicare Advantage plans rating to 3.5 stars, the company added.
Clover Health said its higher overall rating reflects its performance across several measures, including its 4.94 stars out of 5 stars on healthcare effectiveness data and information set.
Price: 4.15, Change: +0.19, Percent Change: +4.94
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.